The humoral response to COVID-19 vaccinations can predict the booster effect on health care workers—toward personalized vaccinations?

Covid-19: Omicron drives weekly record high in global infections

(2022) Luke Taylor   BMJ-British Medical Journal

Correlates of protection against SARS ‐ CoV ‐2 infection and COVID‐19 disease

(2022) David Goldblatt et al.   IMMUNOLOGICAL REVIEWS

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

(2022) Noa Eliakim-Raz et al.   JAMA Network Open

Effectiveness of mRNA COVID-19 Vaccine Boosters Against Infection, Hospitalization, and Death: A Target Trial Emulation in the Omicron (B.1.1.529) Variant Era

(2022) George N. Ioannou et al.   ANNALS OF INTERNAL MEDICINE

Waning of SARS-CoV-2 IgG antibodies after vaccination: first results from the CoMoLo follow-up 2021

(2022) C Kußmaul et al.   EUROPEAN JOURNAL OF PUBLIC HEALTH

Antibody levels after BNT162b2 vaccine booster and SARS-CoV-2 Omicron infection

(2022) Maria Teresa Vietri et al.   VACCINE

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

(2022) Sitthichai Kanokudom et al.   VACCINE

SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort

(2022) Robert W. Aldridge et al.   Nature Communications

Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection

(2022) Mayan Gilboa et al.   JAMA Network Open

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

(2021) Florian Krammer   NATURE MEDICINE

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

(2021) Yinon M. Bar-On et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

(2021) Moriah Bergwerk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

(2021) Stephen J. Thomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waning Immunity after the BNT162b2 Vaccine in Israel

(2021) Yair Goldberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

(2021) Barak Mizrahi et al.   Nature Communications

Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff

(2020) Christopher A Martin et al.   JOURNAL OF PUBLIC HEALTH